Figure 1.
Figure 1. Nox2 deficiency does not alter platelet ROS production in male or female mice. Levels of intracellular ROS, detected by oxidation of CM-H2DCF, were measured in the presence or absence of stimulation with convulxin or thrombin in washed platelets from male (A-B) and female (C-D) WT (+/y or +/+) or Nox2-deficient (−/y or −/−) mice. The fluorescent signal generated as the result of oxidation of CM-H2DCF to CM-DCF is presented as fold change over the signal observed with platelets from sex-matched WT mice without thrombin or convulxin. Data are presented as mean ± standard error (n = 6 or 7 mice in each group). *P < .05 vs. WT (+/y or +/+) without convulxin/thrombin, $P < .05 vs. Nox2-deficient (−/y or −/−) without convulxin/thrombin, @P < .05 vs. WT (+/y or +/+) with thrombin (0.02 U/mL), #P < .05 vs. Nox2-deficient (−/y or −/−) with thrombin (0.02 U/mL), 2-way ANOVA with the Tukey test for multiple comparisons.

Nox2 deficiency does not alter platelet ROS production in male or female mice. Levels of intracellular ROS, detected by oxidation of CM-H2DCF, were measured in the presence or absence of stimulation with convulxin or thrombin in washed platelets from male (A-B) and female (C-D) WT (+/y or +/+) or Nox2-deficient (−/y or −/−) mice. The fluorescent signal generated as the result of oxidation of CM-H2DCF to CM-DCF is presented as fold change over the signal observed with platelets from sex-matched WT mice without thrombin or convulxin. Data are presented as mean ± standard error (n = 6 or 7 mice in each group). *P < .05 vs. WT (+/y or +/+) without convulxin/thrombin, $P < .05 vs. Nox2-deficient (−/y or /) without convulxin/thrombin, @P < .05 vs. WT (+/y or +/+) with thrombin (0.02 U/mL), #P < .05 vs. Nox2-deficient (−/y or /) with thrombin (0.02 U/mL), 2-way ANOVA with the Tukey test for multiple comparisons.

Close Modal

or Create an Account

Close Modal
Close Modal